No Data
HUMAN HEALTH: 2024 Annual Report
human health (01419.HK) fiscal year 2024 earnings approximately 0.591 billion Hong Kong dollars, a year-on-year decrease of approximately 41.0%.
Gelonghui September 25th | Human Health (01419.HK) announced that the group's income in the 2024 fiscal year is approximately 590.8 million Hong Kong dollars, a decrease of about 41.0% from the 2023 fiscal year. This decrease is mainly due to a decrease in revenue of about 509.0 million Hong Kong dollars generated by services related to the 2019 coronavirus disease prevention, testing, vaccine administration, and outreach. Excluding the revenue generated by these services, the group's income increased by about 19.9% compared to the 2023 fiscal year. The company's attributable profit is approximately 24.2 million Hong Kong dollars, a decrease of about 156.6 million Hong Kong dollars or 86.6% from the 2023 fiscal year. Excluding non-financial assets.
human health (01419) will distribute a final dividend of HK$0.028 per share on December 30th.
human health (01419) announced that a dividend will be distributed on December 30, 2024, for the year ending June 3, 2024...
Express News | Human Health Holdings FY Gross Margin 45.7%
HUMAN HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2024; AND FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS
Human Health (01419.HK) plans to hold a board of directors meeting on September 25th to approve the performance.
Glory 12th Sept. Human Health (01419.HK) announced that a meeting of the board of directors will be held on Wednesday, 25th September 2024 at 12/F, Phase 2, Enterprise Square, 3 Hoi Yuen Road, Kwun Tong, Kowloon, Hong Kong, to approve the annual performance of the company and its subsidiaries as of 30th June 2024, and to consider the proposal for the distribution of final dividends (if any).
No Data
No Data